Detalhe da pesquisa
1.
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.
Clin Infect Dis
; 74(9): 1604-1613, 2022 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34323955
2.
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.
Lancet HIV
; 11(4): e211-e221, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38538160
3.
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Week 24 Results From IMPAACT 2014.
J Acquir Immune Defic Syndr
; 92(2): 153-161, 2023 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36215957
4.
Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents.
Clin Pharmacokinet
; 62(10): 1445-1459, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37603217
5.
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014.
J Pediatric Infect Dis Soc
; 12(12): 602-609, 2023 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-37815035
6.
Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study.
Lancet HIV
; 10(8): e506-e517, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37541705
7.
Forty-Eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth With HIV in the United States.
J Acquir Immune Defic Syndr
; 91(3): 296-304, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35839439
8.
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Lancet HIV
; 9(5): e332-e340, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35489377
9.
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States.
J Acquir Immune Defic Syndr
; 88(5): 497-505, 2021 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34483297
10.
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.
J Pediatric Infect Dis Soc
; 10(2): 201-204, 2021 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32448902
11.
Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age.
AIDS
; 35(9): 1413-1421, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33831904
12.
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.
J Pediatric Infect Dis Soc
; 9(2): 159-165, 2020 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-30951600
13.
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis.
AIDS
; 33(14): 2197-2203, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31689263
14.
The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial.
Lancet Glob Health
; 4(12): e978-e988, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27815148
15.
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093.
Pediatr Infect Dis J
; 34(11): 1207-13, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26244832
16.
Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
Antimicrob Agents Chemother
; 46(8): 2554-63, 2002 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12121932